These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26200289)

  • 1. Rare versus Artifactual EGFR Mutations.
    Domingues PM; Montella T; Baldotto C
    J Thorac Oncol; 2015 Aug; 10(8):e79-80. PubMed ID: 26200289
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Rare Versus Artifactual EGFR Mutations.
    Lohinai Z; Ostoros G; Moldvay J; Dome B; Hegedus B
    J Thorac Oncol; 2015 Aug; 10(8):e80-1. PubMed ID: 26200290
    [No Abstract]   [Full Text] [Related]  

  • 3. Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner.
    Akbari M; Hansen MD; Halgunset J; Skorpen F; Krokan HE
    J Mol Diagn; 2005 Feb; 7(1):36-9. PubMed ID: 15681472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.
    Mariani S; Bertero L; Osella-Abate S; Di Bello C; Francia di Celle P; Coppola V; Sapino A; Cassoni P; Marchiò C
    Br J Cancer; 2017 Jul; 117(3):358-366. PubMed ID: 28618430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR-based DNA enrichment enhances detection of mutations in oncology.
    Dowthwaite G; Pickford J
    MLO Med Lab Obs; 2015 Nov; 47(11):18, 20. PubMed ID: 26685421
    [No Abstract]   [Full Text] [Related]  

  • 6. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
    Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
    J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of KLF6 gene mutations in human astrocytic tumors and cell lines.
    Koivisto PA; Zhang X; Sallinen SL; Sallinen P; Helin HJ; Dong JT; Van Meir EG; Haapasalo H; Hyytinen ER
    Int J Cancer; 2004 Sep; 111(4):642-3. PubMed ID: 15239146
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.
    Erster S; Slade N; Moll UM
    Methods Mol Biol; 2003; 234():219-30. PubMed ID: 12824535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct analysis for familial adenomatous polyposis mutations.
    Powell SM
    Methods Mol Biol; 1998; 92():251-66. PubMed ID: 9664521
    [No Abstract]   [Full Text] [Related]  

  • 10. EGFR artifactual mutations associated with two DNA sequencers.
    Yu JJ; Flynn DC
    Biotechniques; 2007 Jan; 42(1):41. PubMed ID: 17269483
    [No Abstract]   [Full Text] [Related]  

  • 11. Duodenal carcinoma in MUTYH-associated polyposis.
    Nielsen M; Poley JW; Verhoef S; van Puijenbroek M; Weiss MM; Burger GT; Dommering CJ; Vasen HF; Kuipers EJ; Wagner A; Morreau H; Hes FJ
    J Clin Pathol; 2006 Nov; 59(11):1212-5. PubMed ID: 16943222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
    Gismondi V; Meta M; Bonelli L; Radice P; Sala P; Bertario L; Viel A; Fornasarig M; Arrigoni A; Gentile M; Ponz de Leon M; Anselmi L; Mareni C; Bruzzi P; Varesco L
    Int J Cancer; 2004 May; 109(5):680-4. PubMed ID: 14999774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.
    Croitoru ME; Cleary SP; Di Nicola N; Manno M; Selander T; Aronson M; Redston M; Cotterchio M; Knight J; Gryfe R; Gallinger S
    J Natl Cancer Inst; 2004 Nov; 96(21):1631-4. PubMed ID: 15523092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
    Pilati C; Shinde J; Alexandrov LB; Assié G; André T; Hélias-Rodzewicz Z; Ducoudray R; Le Corre D; Zucman-Rossi J; Emile JF; Bertherat J; Letouzé E; Laurent-Puig P
    J Pathol; 2017 May; 242(1):10-15. PubMed ID: 28127763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EGFR in bladder cancer.
    Villares GJ; Zigler M; Blehm K; Bogdan C; McConkey D; Colin D; Bar-Eli M
    World J Urol; 2007 Dec; 25(6):573-9. PubMed ID: 17690890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition.
    Broderick P; Bagratuni T; Vijayakrishnan J; Lubbe S; Chandler I; Houlston RS
    BMC Cancer; 2006 Oct; 6():243. PubMed ID: 17029639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.
    Baudhuin LM; Roberts LR; Enders FT; Swanson RL; Mettler TA; Aderca I; Stadheim LM; Highsmith WE
    J Cancer Res Clin Oncol; 2006 Mar; 132(3):159-62. PubMed ID: 16292541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis using enriched PCR and cycle sequencing.
    Mitchell KR; Warshawsky D
    Biotechniques; 1998 Jun; 24(6):1028-31. PubMed ID: 9631198
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
    Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutation detection by SSCP and sequencing.
    Hakkarainen J; Welsh JA; Vähäkangas KH
    Methods Mol Med; 2004; 97():191-208. PubMed ID: 15064494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.